Record NAL revenue but lower FY26 guidance for Elevra (NASDAQ: ELVR)
Elevra Lithium reported a record quarter at its North American Lithium (NAL) mine, with revenue of US$66 million driven by sales of 66,016 dmt of spodumene concentrate at an average realised price of US$998/dmt FOB. Sales volumes rose 154% quarter on quarter and pricing increased 27%, while unit operating costs were broadly flat at US$812/dmt.
Operationally, ore mined grew 15% but lower lithium grades and higher iron content cut recovery to 62% and reduced concentrate production by 15% to 44,154 dmt. In response, Elevra lowered FY2026 production guidance to 180,000–190,000 dmt and raised unit cost guidance to US$860–US$880/dmt, reflecting short-term spending on grade control and ore blending.
The company ended the quarter with US$81 million in cash after NAL generated US$12 million profit from operations and US$13 million net operating cash inflow. Growth work continued on the NAL brownfield expansion, Moblan, Ewoyaa and Carolina Lithium, with an accelerated NAL expansion plan targeting a staged 15–20% output increase by mid-CY2027.
Positive
- None.
Negative
- FY2026 outlook reduced and costs higher: Spodumene production guidance was cut from 195,000–210,000 dmt to 180,000–190,000 dmt and unit cost guidance increased to US$860–US$880/dmt, reflecting lower recoveries and additional short-term spending.
Insights
Record NAL revenue but weaker grades force Elevra to cut FY2026 guidance.
Elevra delivered a strong pricing-led quarter at NAL, with revenue of
The downgrade of FY2026 spodumene production guidance to
Cash ended at
| Form 20-F ☒ | Form 40-F ☐ |

| • |
Second best quarterly safety performance since recommencing operations in 2023.
|
| • |
Ore mined of 389,801 wet metric tonnes (wmt) was 15% higher quarter on quarter (QoQ).
|
| • |
Process plant utilisation improved to 89%, a 2% increase QoQ.
|
| • |
Lithium recovery for the quarter was 62%, down 7% QoQ as a consequence of pit development sequencing adjacent to historical underground workings which in turn resulted in
temporary lower feed grade and a larger proportion of higher iron content in feed material.
|
| • |
Spodumene concentrate production declined by 15% QoQ to 44,154 dry metric tonnes (dmt) at an average grade of 4.9%. The reduced concentrate production and grade were a
function of lower lithium recovery, as the higher iron content necessitated increased use of the WHIMS (wet high intensity magnetic separators).
|
| • |
Spodumene sales were 66,016 dmt, in line with prior guidance to weight sales toward the December 2025 quarter1. There were two cargoes sold during the December 2025 quarter which aligns with Elevra’s strategy to ship larger cargoes to achieve freight savings.
|
| • |
The average realised selling price (FOB) increased by 27% to US$998/dmt versus the prior quarter, reflecting the benefit of improved lithium market fundamentals and
Elevra’s leverage to rising spot prices.
|
| • |
Unit operating costs (per tonne sold) for NAL were US$812/dmt, a modest decrease compared to US$818 in the prior quarter, resulting in NAL generating a quarterly gross
profit for the second time since the restart of operations.
|
| • |
Capital expenditure of US$7 million for the quarter was on budget and primarily related to the upgrade of the Tailings Storage Facility and other NAL sustaining projects.
|
|
1
|
See ASX release 15 September 2025 “Market Update Presentation”.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
1 |

| • |
Following completion of the December 2025 quarter, Elevra issued an update on the NAL Expansion which offered an accelerated timeline to increase
annual production and reduce unit operating costs by implementing a phased approach to the expansion2.
|
| • |
Planned baseline environmental field activities were undertaken during the December 2025 quarter and studies progressed.
|
| • |
Ratification of the Ewoyaa Mining Lease by the Parliament of Ghana is ongoing. Advancement of the project remains contingent on Mining Lease ratification,
prevailing market conditions and the availability and structure of suitable project financing.
|
| • |
During the December 2025 quarter, Carolina Lithium obtained General Stormwater Permits for the proposed mine and conversion plant advancing key environmental
permitting milestones.
|
| • |
In addition, Elevra engaged with local officials, community stakeholders and relevant US government agencies in relation to the next stages of project development,
including discussions related to the project’s strategic importance to a US domestic lithium supply chain.
|
| • |
Cash at the December 2025 quarter end was US$81 million, reflecting change-of-control payments and merger-related advisory fees incurred during the period.
|
| • |
Elevra appointed Christian Cortes as Chief Financial Officer during the quarter, supporting the Company’s operational focus and continued development and growth
initiatives.
|
| • |
All resolutions were successfully passed at the Elevra AGM on 21 November 2025, including election of the four selected ex-Piedmont directors.
|
| • |
Merger related cost synergies remain on track to deliver targeted savings. An update will be provided with the HY26 Interim Results in late February 2026.
|
| • |
Elevra has revised FY2026 production, sales and cost guidance after reviewing results for the half year - providing a more conservative outlook for the next
several quarters. The Company believes it prudent to lower production guidance for the short term until the benefits of increased grade control drilling and improved ore blending are realised. The current operational conditions are not
representative of the NAL Life of Mine (LOM) orebody, hence the adjustment applies to near term guidance only.
|
|
Unit
|
Current Guidance
|
Prior Guidance3
|
|
|
Spodumene concentrate production
|
Dmt
|
180,000 - 190,000
|
195,000 –210,000
|
|
Spodumene concentrate sales
|
Dmt
|
170,000 - 190,000
|
195,000 –210,000
|
|
Unit operating cost sold
|
US$/dmt
|
US$860 – US$880
|
US$765–US$830
|
|
Capital expenditures
|
US$M
|
US$26
|
US$26
|
|
2
|
See ASX release 12 January 2026 “Accelerated NAL Expansion”.
|
|
3
|
As a result of the Company’s transition from reporting in Australian dollars to US dollars, the prior guidance ranges for unit operating cost sold
and capital expenditures have been converted using AUD:USD = 0.65.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
2 |

|
QUARTERLY ACTIVITIES REPORT • December 2025
|
3 |

|
Unit
|
Q2
FY26
|
Q1
FY26
|
QoQ
Variance
|
YTD
FY26
|
YTD
FY25
|
YTD
Variance
|
||||
|
North American Lithium4
|
||||||||||
|
Ore mined
|
wmt
|
389,801
|
338,341
|
15%
|
728,142
|
610,683
|
19%
|
|||
|
Recovery
|
%
|
62
|
69
|
(7%)
|
66
|
67
|
(1%)
|
|||
|
Concentrate produced
|
dmt
|
44,154
|
52,003
|
(15%)
|
96,156
|
103,063
|
(7%)
|
|||
|
Concentrate grade produced
|
%
|
4.9
|
5.2
|
(0.3%)
|
5.0
|
5.3
|
(0.3%)
|
|||
|
Concentrate sold
|
dmt
|
66,016
|
25,975
|
154%
|
91,991
|
115,027
|
(20%)
|
|||
|
Average realised selling price (FOB)5
|
US$/dmt
|
998
|
784
|
27%
|
937
|
697
|
35%
|
|||
|
Revenue
|
US$M
|
66
|
20
|
223%
|
86
|
80
|
8%
|
|||
|
Unit operating cost sold (FOB)6
|
US$/dmt
|
812
|
818
|
(0.7%)
|
814
|
861
|
(6%)
|
|||
|
Group
|
||||||||||
|
Cash balance
|
US$M
|
81
|
98
|
(17%)
|
81
|
69
|
17%
|
|||
|
USD : CAD
|
$
|
1,394
|
1.377
|
1%
|
1,386
|
1.382
|
—
|
|||
|
USD : AUD
|
$
|
1,523
|
1.528
|
—
|
1,526
|
1.513
|
1%
|
|||
|
4
|
Numbers presented may not add up precisely to the totals provided due to rounding.
|
|
5
|
Average realised selling price is calculated on an accruals basis and reported in US$/dmt sold, FOB Port of Québec.
|
|
6
|
Unit operating cost sold is calculated on an accruals basis and includes mining, processing, transport, port charges, site-based general and
administration costs and cash based inventory movements, and excludes depreciation and amortization charges, freight and royalties. It is reported in US$/dmt sold, FOB Port of Québec.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
4 |


|
QUARTERLY ACTIVITIES REPORT • December 2025
|
5 |



|
QUARTERLY ACTIVITIES REPORT • December 2025
|
6 |

|
QUARTERLY ACTIVITIES REPORT • December 2025
|
7 |


|
7
|
See ASX release 15 September 2025, “NAL Expansion Scoping Study”.
|
|
8
|
See ASX release 12 January 2026, “Accelerated NAL Expansion”.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
8 |

|
9
|
See ASX release 25 November 2025, “1MC:Mt Edon Rubidium Testwork Confirms High Grade Recoveries”.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
9 |


|
Unit
|
Current Guidance
|
Prior Guidance10
|
|
|
Spodumene concentrate production
|
dmt
|
180,000 - 190,000
|
195,000 –210,000
|
|
Spodumene concentrate sales
|
dmt
|
170,000 - 190,000
|
195,000 –210,000
|
|
Unit operating cost sold
|
US$/dmt
|
US$860 – US$880
|
US$765–US$830
|
|
Capital expenditures
|
US$M
|
US$26
|
US$26
|
|
10
|
As a result of the Company’s transition from reporting in Australian dollars to US dollars, the prior guidance ranges for unit operating cost sold and capital
expenditures have been converted using AUD:USD = 0.65.
|
|
11
|
See ASX release 20 October 2025, “Resignation and Appointment of CFO”.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
10 |


| • |
169,329,111 ordinary fully paid shares;
|
| • |
2,723,613 unquoted options expiring on 31 December 2028;
|
| • |
1,760,737 unquoted performance rights (expiring various dates).
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
11 |


| • |
All references to dollars and cents are United States currency, unless otherwise stated.
|
| • |
Numbers presented may not add up precisely to the totals provided due to rounding.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
12 |


|
QUARTERLY ACTIVITIES REPORT • December 2025
|
13 |

|
Unit
|
Q2 FY25
|
Q3 FY25
|
Q4 FY25
|
Q1 FY26
|
Q2 FY26
|
|||
|
Physicals12
|
||||||||
|
Ore mined
|
wmt
|
370,409
|
322,407
|
361,883
|
338,341
|
389,801
|
||
|
Ore crushed
|
wmt
|
342,752
|
292,962
|
379,353
|
349,698
|
361,485
|
||
|
Ore processed
|
dmt
|
342,855
|
287,782
|
357,290
|
341,780
|
351,592
|
||
|
Concentrate produced
|
dmt
|
50,922
|
43,261
|
58,533
|
52,003
|
44,154
|
||
|
Concentrate sold
|
dmt
|
66,035
|
27,030
|
66,980
|
25,975
|
66,016
|
||
|
Unit Metrics
|
||||||||
|
Average realised selling price (FOB)13Error! Bookmark not
defined.
|
US$/dmt
|
686
|
710
|
682
|
784
|
998
|
||
|
Unit operating cost sold (FOB)14
|
US$/dmt
|
837
|
830
|
791
|
818
|
812
|
||
|
Production Variables
|
||||||||
|
Mill utilisation
|
%
|
90%
|
80%
|
93%
|
87%
|
89%
|
||
|
Recovery
|
%
|
68%
|
69%
|
73%
|
69%
|
62%
|
||
|
Concentrate grade produced
|
%
|
5.3%
|
5.2%
|
5.2%
|
5.2%
|
4.9%
|
||
|
12
|
Numbers presented may not add up precisely to the totals provided due to rounding.
|
|
13
|
Average realised selling price is calculated on an accruals basis and reported in US$/dmt sold, FOB Port of Québec.
|
|
14
|
Unit operating cost sold is calculated on an accruals basis and includes mining, processing, transport, port charges, site-based general and
administration costs and cash based inventory movements, and excludes depreciation and amortisation charges, freight and royalties. It is reported in US$/dmt sold, FOB Port of Québec.
|
|
QUARTERLY ACTIVITIES REPORT • December 2025
|
14 |
|
ELEVRA LITHIUM LIMITED
|
||
|
Date: January 28, 2026
|
By:
|
/s/ Dylan Roberts
|
|
Name: Dylan Roberts
|
||
|
Title: Company Secretary and General
Counsel
|
||